Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Change in Taxes: 2020-2021

Historic Change in Taxes for Nurix Therapeutics (NRIX) over the last 1 years, with Aug 2021 value amounting to -$2.9 million.

  • Nurix Therapeutics' Change in Taxes rose 81.33% to -$2.9 million in Q3 2021 from the same period last year, while for Aug 2021 it was -$3.7 million, marking a year-over-year change of. This contributed to the annual value of -$3.6 million for FY2021, which is 194.70% down from last year.
  • As of Q3 2021, Nurix Therapeutics' Change in Taxes stood at -$2.9 million, which was down 250.18% from -$839,000 recorded in Q2 2021.
  • Over the past 5 years, Nurix Therapeutics' Change in Taxes peaked at $135,000 during Q1 2021, and registered a low of -$15.7 million during Q3 2020.
  • Moreover, its 2-year median value for Change in Taxes was -$839,000 (2021), whereas its average is -$3.9 million.
  • Data for Nurix Therapeutics' Change in Taxes shows a peak YoY spiked of 81.33% (in 2021) over the last 5 years.
  • Over the past 2 years, Nurix Therapeutics' Change in Taxes (Quarterly) stood at -$10,000 in 2020, then soared by 81.33% to -$2.9 million in 2021.
  • Its Change in Taxes was -$2.9 million in Q3 2021, compared to -$839,000 in Q2 2021 and $135,000 in Q1 2021.